Browsing Tag
Denifanstat
2 posts
Can Sagimet turn denifanstat into a multi-indication platform and licensing engine beyond acne?
Can Sagimet parlay its acne win into a licensing engine and platform biotech story? Explore how FASN inhibition is being redefined across diseases.
Denifanstat phase 3 acne trial success positions Ascletis for China NDA submission in 2026
Find out how Denifanstat’s Phase 3 acne trial success positions Ascletis Pharma for a 2026 China NDA submission and reshapes the acne-therapy market.